|
NHEJ1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.000970E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.873700E-02 |
| Normal-vs-Stage2 |
7.404400E-01 |
| Normal-vs-Stage3 |
4.472200E-01 |
| Normal-vs-Stage4 |
2.253000E-01 |
| Stage1-vs-Stage2 |
4.060300E-02 |
| Stage1-vs-Stage3 |
1.560640E-01 |
| Stage1-vs-Stage4 |
6.690800E-01 |
| Stage2-vs-Stage3 |
3.010000E-01 |
| Stage2-vs-Stage4 |
1.802190E-01 |
| Stage3-vs-Stage4 |
5.338800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.475240E-01 |
| Normal-vs-AfricanAmerican |
4.096000E-01 |
| Normal-vs-Asian |
1.642410E-02 |
| Caucasian-vs-AfricanAmerican |
9.479200E-01 |
| Caucasian-vs-Asian |
9.574200E-02 |
| AfricanAmerican-vs-Asian |
2.577000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.689000E-01 |
| Normal-vs-Female |
8.691800E-02 |
| Male-vs-Female |
6.542200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.571540E-02 |
| Normal-vs-Age(41-60Yrs) |
4.982400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.770000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.531200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.478000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.224640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.124000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.757000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.130000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.731600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.415200E-01 |
| Classical-VS-Follicular |
4.30039999999021E-06 |
| Classical-VS-Other |
7.205000E-01 |
| Classical-VS-Normal |
2.945700E-02 |
| Tall-VS-Follicular |
7.607000E-04 |
| Tall-VS-Other |
3.614800E-01 |
| Tall-VS-Normal |
6.603100E-03 |
| Follicular-VS-Other |
3.092600E-01 |
| Follicular-VS-Normal |
1.529000E-01 |
| Other-VS-Normal |
5.530000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.124400E-01 |
| Normal-vs-N1 |
9.334400E-01 |
| N0-vs-N1 |
4.360200E-01 |
|
|
